These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26610618)

  • 1. Screening of inhibitors of glycogen synthase kinase-3β from traditional Chinese medicines using enzyme-immobilized magnetic beads combined with high-performance liquid chromatography.
    Li Y; Xu J; Chen Y; Mei Z; Xiao Y
    J Chromatogr A; 2015 Dec; 1425():8-16. PubMed ID: 26610618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rosmarinic Acid Derivatives' Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer's Disease.
    Paudel P; Seong SH; Zhou Y; Park CH; Yokozawa T; Jung HA; Choi JS
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30413117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
    Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake.
    Zhang P; Li S; Gao Y; Lu W; Huang K; Ye D; Li X; Chu Y
    Bioorg Med Chem Lett; 2014 Dec; 24(24):5639-5643. PubMed ID: 25467150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ESI-MS/MS method for screening of small-molecule mixtures against glycogen synthase kinase-3beta (GSK-3beta).
    Partserniak I; Werstuck G; Capretta A; Brennan JD
    Chembiochem; 2008 May; 9(7):1065-73. PubMed ID: 18348127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of an ESI-QTOF method for the detailed characterization of GSK-3β inhibitors.
    De Simone A; Fiori J; Naldi M; D'Urzo A; Tumiatti V; Milelli A; Andrisano V
    J Pharm Biomed Anal; 2017 Sep; 144():159-166. PubMed ID: 28268049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct determination of GSK-3β activity and inhibition by UHPLC-UV-vis diode arrays detector (DAD).
    D'Urzo A; De Simone A; Fiori J; Naldi M; Milelli A; Andrisano V
    J Pharm Biomed Anal; 2016 May; 124():104-111. PubMed ID: 26942334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of small molecules that inhibit GSK-3beta through virtual screening.
    Kang NS; Lee GN; Kim CH; Bae MA; Kim I; Cho YS
    Bioorg Med Chem Lett; 2009 Jan; 19(2):533-7. PubMed ID: 19081248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mass spectrometry-based assay for GSK-3beta activity.
    Bowley E; Mulvihill E; Howard JC; Pak BJ; Gan BS; O'Gorman DB
    BMC Biochem; 2005 Dec; 6():29. PubMed ID: 16359552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery and anti-inflammatory evaluation of benzothiazepinones (BTZs) as novel non-ATP competitive inhibitors of glycogen synthase kinase-3β (GSK-3β).
    Gao Y; Zhang P; Cui A; Ye DY; Xiang M; Chu Y
    Bioorg Med Chem; 2018 Nov; 26(20):5479-5493. PubMed ID: 30293796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid screening and identification of α-amylase inhibitors from Garcinia xanthochymus using enzyme-immobilized magnetic nanoparticles coupled with HPLC and MS.
    Li Y; Chen Y; Xiao C; Chen D; Xiao Y; Mei Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():166-73. PubMed ID: 24814002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and in vitro evaluation of new leads as selective and competitive glycogen synthase kinase-3β inhibitors through ligand and structure based drug design.
    Darshit BS; Balaji B; Rani P; Ramanathan M
    J Mol Graph Model; 2014 Sep; 53():31-47. PubMed ID: 25064440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glycogen synthase kinase-3β by Angelica sinensis extract decreases β-amyloid-induced neurotoxicity and tau phosphorylation in cultured cortical neurons.
    Zhang Z; Zhao R; Qi J; Wen S; Tang Y; Wang D
    J Neurosci Res; 2011 Mar; 89(3):437-47. PubMed ID: 21259330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of high performance liquid chromatography with immobilized enzyme onto magnetic nanospheres for screening enzyme inhibitor.
    Hu F; Deng C; Zhang X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):67-71. PubMed ID: 18606577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
    Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
    Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
    Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
    Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (Z)-2-(3-Chlorobenzylidene)-3,4-dihydro-N-(2-methoxyethyl)-3-oxo-2H-benzo[b][1,4]oxazine-6-carboxamide as GSK-3β inhibitor: Identification by virtual screening and its validation in enzyme- and cell-based assay.
    Joshi P; Gupta M; Vishwakarma RA; Kumar A; Bharate SB
    Chem Biol Drug Des; 2017 Jun; 89(6):964-971. PubMed ID: 27896926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Andrographolide activates the canonical Wnt signalling pathway by a mechanism that implicates the non-ATP competitive inhibition of GSK-3β: autoregulation of GSK-3β in vivo.
    Tapia-Rojas C; Schüller A; Lindsay CB; Ureta RC; Mejías-Reyes C; Hancke J; Melo F; Inestrosa NC
    Biochem J; 2015 Mar; 466(2):415-30. PubMed ID: 25423492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycogen synthase kinase-3beta is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts.
    Kandasamy AD; Schulz R
    Cardiovasc Res; 2009 Sep; 83(4):698-706. PubMed ID: 19493954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation.
    Neumann M; Klar S; Wilisch-Neumann A; Hollenbach E; Kavuri S; Leverkus M; Kandolf R; Brunner-Weinzierl MC; Klingel K
    Oncogene; 2011 May; 30(21):2485-92. PubMed ID: 21217772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.